Combined Effect Of Cranial And Cervical Mobilization In Patients With CGH

January 14, 2023 updated by: Mennat Allah Hussien Mahmoud Mouhamed, Cairo University

Combined Effect Of Cranial And Cervical Mobilization In Patients With Cervicogenic Headache

  • The purposes of this study are:

  • To investigate the combined effect of cranial and cervical mobilization in patient with cervicogenic headache and there effect on :

    1. Perceptive neck pain intensity
    2. Perceptive headache intensity
    3. pain by pressure
    4. frequency of headache episodes
    5. duration of headache episodes
    6. Medications uptakes

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. pain originating at the neck and radiating to oculo-frontal-temporal regions.

    2. symptom unilaterally. 3. symptom provocation through cervical movement and/or awkward cervical postural. 4. symptom provocation through external pressure application through palpation to associated posterior cervical spine segments with resultant symptom reproduction. 5. possible ipsilateral shoulder and/or arm pain of vague reference. 6. 15 or more headache episodes per month 7. No history of cervical operation or any disease that result in headache as colities 8-All patients will sign the informed consent before joining the study.

Exclusion Criteria:

  • Headache not of cervical origin 2- Headache with autonomic involvement, dizziness, or visual disturbance 3- Congenital conditions of the cervical spine 4-It is of primary concern to exclude serious or life-threatening pathology such as : A. cranial tumors. B. Meningitis. C. sub-arachnoid hemorrhage. D. carotid artery,vertebral artery dissection. 5- History of cervical operation or any disease that result in headache as colitis 6-Age less than 18 or more than 40 years 7- chronic maxillary sinusitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Other: Mobilization Techniques
Combination of Cranial and Cervical Mobilization for Cervicogenic headache Patients treatment
Other: Conventional Treatment
Conventional Treatment
Active Comparator: Control Group
Other: Conventional Treatment
Conventional Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assis Headache Frequency episodes
Time Frame: 2 weeks
By patient questionnaire or interview
2 weeks
Assis Headache Perceptive intensity
Time Frame: 2 weeks
By visual analog scale
2 weeks
Assis Headache duration episodes
Time Frame: 2 weeks
By patient questionnaire or interview
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2023

Primary Completion (Anticipated)

August 1, 2023

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

December 29, 2022

First Submitted That Met QC Criteria

January 14, 2023

First Posted (Estimate)

January 25, 2023

Study Record Updates

Last Update Posted (Estimate)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 14, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Mobilization In CGH Treatment

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Mobilization Techniques

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe